Active Not Recruiting OBSERVATIONAL NCT06514196

Post- Approval Hintermann Series H® Study 1

Post- Approval Study 1: Long Term Follow Up of the Hintermann Series H® Total Ankle Replacement System

Sponsor: DT MedTech, LLC

Conditions Ankle Osteoarthritis Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder) Post-Traumatic Osteoarthritis of Ankle

Interventions Hintermann Series H3 Total Ankle Replacement System

Updated 2 times since 2024 Last updated: Jul 16, 2024 Started: Jun 18, 2020 Primary completion: Nov 30, 2024 Completion: Jan 20, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06514196, this observational or N/A phase trial focuses on Ankle Osteoarthritis and Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder) and remains ongoing. Sponsored by DT MedTech, LLC, it has been updated 2 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2024 — Present [monthly]

Active Not Recruiting
Aug 2024 — Sep 2024 [monthly]

Active Not Recruiting

First recorded

Jun 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DT MedTech, LLC

Data source: DT MedTech, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bruderholz, Switzerland